Concepedia

Brett L. Hurst

BL

Statistics

Publications

56

Citations

5.8K

H-Index

32

Active since

2007

Affiliations

Utah State University(Current)

University of North Carolina at Chapel Hill

University of Arizona

Pfizer (United States)

University of California San Diego

Brett L. Hurst is an author at Utah State University specializing in virology, molecular virology, and infectious diseases.

Publications per year

2007–2025

56

Publications

56

An oral SARS-CoV-2 M <sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Chunlong Ma, M. Sacco, Brett L. Hurst et al. · Cell Research · 2020 · 885 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L

M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 399 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +14

A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells

Drake M. Mellott, Chien‐Te K. Tseng, Aleksandra Drelich et al. · ACS Chemical Biology · 2021 · 122 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity

Michael D. Swanson, Daniel M. Boudreaux, Loïc Salmon et al. · Cell · 2015 · 119 citations · Full text

Life Sciences, Biochemistry, Immunology +13

1–5 of 56